HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Despite enticing data, future of vitamin D in cancer therapy remains unknown
• Health workers vital to tobacco-control efforts for smokers with cancer Michael B. Steinberg, MD, MPH, FACP
• Addition of pemetrexed to cisplatin did not boost survival in head and neck cancers
• Anti-Müllerian hormone may signal gonadotoxicity in girls treated for cancer
• Breast cancer treatments may affect cognitive function
• Brentuximab vedotin induced response in patients with relapsed, refractory HL
• Changes in bone mineral density occur soon after intermittent ADT
• Clinical course of refractory anemia with ring sideroblasts, marked thrombocytosis better defined
• Diesel exhaust exposure linked to increased risk for lung cancer mortality
• Education may ensure integration of palliative care
• Prophylaxis with Factor VIII improved bleeding events in hemophilia A
• Radionuclide therapy may be linked to hematologic consequences in neuroendocrine tumors
• Reduced-intensity BEACOPP more effective, less toxic for HL patients
• Response to APL treatment differed in children younger than 4 years
• Robotic-assisted radical cystectomy resulted in fewer deaths, higher cost
• Score based on gene expression helped predict response to platinum therapy
• Study finds poor are less likely to sue their physicians
• Teenage alcohol consumption linked to increased breast cancer risk
• Treatment of depression did not alter survival in lung cancer patients
• Type 2 diabetes-related variants, gender affect colorectal cancer risk
• Lessons learned in difficult days can help physicians become effective providers from beginning to end William Wood, MD
• Asians experienced chemo brain after treatment for breast cancer
• CALGB 90401: VEGF inhibitor did not improve outcomes for metastatic prostate cancer
• Complications after esophageal cancer surgery lead to long-term health issues
• DF3/MUC1 expression independently predicted poor prognosis in oral squamous cell carcinoma
• Individualized psychotherapy provided short-term benefits in end-stage cancer patients
• More than half of cancers may be preventable using existing resources
• OCEANS: Addition of bevacizumab to chemotherapy increased PFS in ovarian cancers
• Symptom burden, fatigue increased cancer worry among breast cancer survivors
• Warfarin appears to remain effective choice for stroke risk reduction
• Untreated varicose veins put patients at greater DVT risk following THA
• Report reveals significant gaps in global awareness of tobacco's CV risks
• Words matter when clinicians discuss palliative care with patients Stephanie M. Harman, MD, FACP
• Vemurafenib: Pioneering personalized medicine for advanced melanoma Van A. Trinh, PharmD, BCOP; Jennifer Davis, PharmD, BCOP